Related Experiment Video

Updated: Jun 5, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

The effects of endothelial dysfunction and inflammation on slow coronary flow

Hasan Arı1, Selma Arı, Ercan Erdoğan

  • 1Department of Cardiology, Bursa Yüksek İhtisas Heart-Education and Research Hospital, Bursa, Turkey. hasanari03@yahoo.com

Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|January 5, 2011
PubMed

Insights

Endothelial dysfunction, indicated by elevated asymmetric dimethylarginine (ADMA) and reduced flow-mediated dilatation (FMD), is linked to slow coronary flow (SCF). Inflammation does not appear to be a significant factor in SCF development.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomedical Research

Background:

  • Slow coronary flow (SCF) is a condition affecting coronary artery blood flow.
  • The underlying mechanisms of SCF, particularly the roles of endothelial dysfunction and inflammation, require further elucidation.

Purpose of the Study:

  • To investigate the association between endothelial dysfunction and inflammation in patients with slow coronary flow (SCF).

Main Methods:

  • Compared 26 SCF patients with 25 controls using TIMI frame count for coronary flow.
  • Assessed endothelial function via plasma ADMA, flow-mediated dilatation (FMD), and nitroglycerin-mediated dilatation (NMD).
  • Measured inflammation using high-sensitivity C-reactive protein (hs-CRP).

Main Results:

  • SCF patients exhibited significantly higher TIMI frame counts, lower FMD, and higher ADMA levels compared to controls.
  • No significant differences in NMD or hs-CRP were observed between groups.
  • ADMA and FMD were significant predictors of SCF in multivariate analysis, while hs-CRP was not.

Conclusions:

  • Endothelial dysfunction, characterized by elevated ADMA and impaired FMD, is implicated in the pathogenesis of slow coronary flow.
  • Inflammation, as assessed by hs-CRP, does not appear to play a significant role in the development of SCF.
Abstract

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...